Young H. Koh
Goyang, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Annotation-Efficient Deep Learning Model for Pancreatic Cancer Diagnosis and Classification Using CT Images: A Retrospective Diagnostic Study.
Journal: Cancers
Published: May 26, 2023
A case of successful surgical treatment for peritoneal seeding of hepatocellular carcinoma after radiotherapy and atezolizumab plus bevacizumab combination treatment.
Journal: Journal of liver cancer
Published: January 12, 2023
2022 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for Local Ablation Therapy of Hepatocellular Carcinoma: What's New?
Journal: Korean journal of radiology
Published: August 06, 2022
2022 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for Imaging Diagnosis of Hepatocellular Carcinoma: What's New?
Journal: Korean journal of radiology
Published: August 01, 2022
Capecitabine and temozolomide for metastatic intermediate to high-grade pancreatic neuroendocrine neoplasm: a single center experience.
Journal: The Korean journal of internal medicine
Published: March 15, 2022
Sorafenib combined with radiation therapy for advanced hepatocellular carcinoma with portal and hepatic vein invasion extending to the inferior vena cava: a complete response case according to modified RECIST criteria.
Journal: Journal of liver cancer
Published: December 15, 2021
Better survival of patients with hepatitis B virus-related hepatocellular carcinoma in South Korea: Changes in 16-years cohorts.
Journal: PloS one
Published: November 28, 2021
Outcome of Initial Progression During Nivolumab Treatment for Hepatocellular Carcinoma: Should We Use iRECIST?
Journal: Frontiers in medicine
Published: September 07, 2021
Varices on computed tomography as predictor of survival after hepatic resection in patients with single hepatocellular carcinoma.
Journal: Journal of gastroenterology and hepatology
Published: March 17, 2020
Oncological Benefits of Neoadjuvant Chemoradiation With Gemcitabine Versus Upfront Surgery in Patients With Borderline Resectable Pancreatic Cancer: A Prospective, Randomized, Open-label, Multicenter Phase 2/3 Trial.
Journal: Annals of surgery
Published: February 21, 2018
Efficacy of pancreatic exocrine replacement therapy for patients with unresectable pancreatic cancer in a randomized trial.
Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
Published: May 12, 2016
Last Updated: 09/26/2026